{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:04:53Z","timestamp":1790521493926,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U 01 HL72524"],"award-info":[{"award-number":["U 01 HL72524"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["-84338"],"award-info":[{"award-number":["-84338"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["10469"],"award-info":[{"award-number":["10469"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["95330"],"award-info":[{"award-number":["95330"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.dld.2011.10.025","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T12:27:07Z","timestamp":1323606427000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study"],"prefix":"10.1016","volume":"44","author":[{"given":"Jocelyn","family":"Trottier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Bia\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Straka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Heathcote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2011.10.025_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1751-2980.2010.00427.x","article-title":"Pharmacotherapy of cholestatic liver diseases","volume":"11","author":"Paumgartner","year":"2010","journal-title":"J Dig Dis"},{"key":"10.1016\/j.dld.2011.10.025_bib0010","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.3748\/wjg.14.3313","article-title":"Clinical features and management of primary biliary cirrhosis","volume":"14","author":"Crosignani","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.10.025_bib0015","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3748\/wjg.14.3338","article-title":"Clinical features and management of primary sclerosing cholangitis","volume":"14","author":"Silveira","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.10.025_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cld.2007.11.013","article-title":"Medical treatment of cholestatic liver disease","volume":"12","author":"Paumgartner","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2011.10.025_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-009-0154-7","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"31","author":"Aron","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.dld.2011.10.025_bib0030","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.3748\/wjg.v12.i22.3487","article-title":"Ursodeoxycholic acid treatment of vanishing bile duct syndromes","volume":"12","author":"Pusl","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.10.025_bib0035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3748\/wjg.15.804","article-title":"Bile acids: chemistry, physiology, and pathophysiology","volume":"15","author":"Monte","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.10.025_bib0040","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dld.2011.10.025_bib0045","first-page":"24","article-title":"Bile acids: the good, the bad, and the ugly","volume":"14","author":"Hofmann","year":"1999","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.dld.2011.10.025_bib0050","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/hep.1840200632","article-title":"Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose\u2013response study in isolated rat liver mitochondria","volume":"20","author":"Krahenbuhl","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.10.025_bib0055","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.10.025_bib0060","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1016\/j.bmc.2010.07.030","article-title":"Bile acid toxicity structure\u2013activity relationships: correlations between cell viability and lipophilicity in a panel of new and known bile acids using an oesophageal cell line (HET-1A)","volume":"18","author":"Sharma","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.dld.2011.10.025_bib0065","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1515\/CCLM.2003.247","article-title":"Quantitative analysis of bile acids in human plasma by liquid chromatography\u2013electrospray tandem mass spectrometry: a simple and rapid one-step method","volume":"41","author":"Tagliacozzi","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.dld.2011.10.025_bib0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000198952","article-title":"Serum concentrations of bile acid glucuronides in hepatobiliary diseases","volume":"27","author":"Takikawa","year":"1983","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2011.10.025_bib0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1440-1746.1996.tb00064.x","article-title":"Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease","volume":"11","author":"Azer","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2011.10.025_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1194\/jlr.R001941","article-title":"Bile acids: analysis in biological fluids and tissues","volume":"51","author":"Griffiths","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dld.2011.10.025_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2009.11.019","article-title":"High performance liquid chromatography\u2013tandem mass spectrometry for the determination of bile acid concentrations in human plasma","volume":"878","author":"Xiang","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.dld.2011.10.025_bib0090","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.dld.2011.10.025_bib0095","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/ATVBAHA.107.140103","article-title":"Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study","volume":"27","author":"Lai","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dld.2011.10.025_bib0100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/dc07-1687","article-title":"Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study","volume":"31","author":"Shen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2011.10.025_bib0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.ejhg.5202003","article-title":"The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment","volume":"16","author":"Smith","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.dld.2011.10.025_bib0110","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1194\/jlr.P001834","article-title":"ApoB genetic variants modify the response to fenofibrate: a GOLDN study","volume":"51","author":"Wojczynski","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dld.2011.10.025_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/clpt.2011.124","article-title":"Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate","volume":"90","author":"Trottier","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dld.2011.10.025_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2007.09.031","article-title":"High-performance liquid chromatography\u2013tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy","volume":"860","author":"Ye","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.dld.2011.10.025_bib0125","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2011.10.025_bib0130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.10.025_bib0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0168-8278(97)80181-X","article-title":"Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy","volume":"27","author":"Meng","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.10.025_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2004.06.001","article-title":"Mitochondrially-mediated toxicity of bile acids","volume":"203","author":"Palmeira","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.dld.2011.10.025_bib0145","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3748\/wjg.15.3134","article-title":"Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease","volume":"15","author":"Gnewuch","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.10.025_bib0150","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity","volume":"36","author":"Hofmann","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dld.2011.10.025_bib0155","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.dld.2011.10.025_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11894-009-0079-2","article-title":"Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis","volume":"12","author":"Zein","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.dld.2011.10.025_bib0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.10.025_bib0170","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.freeradbiomed.2005.07.005","article-title":"Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage","volume":"39","author":"Komichi","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.dld.2011.10.025_bib0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dld.2011.10.025_bib0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2362.2000.00615.x","article-title":"Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes","volume":"30","author":"Benz","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2011.10.025_bib0185","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1440-1746.2006.04363.x","article-title":"Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes","volume":"21","author":"Hirano","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2011.10.025_bib0190","doi-asserted-by":"crossref","first-page":"20210","DOI":"10.1074\/jbc.M909992199","article-title":"The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade","volume":"275","author":"Rust","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811004257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811004257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:08:32Z","timestamp":1761624512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865811004257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1590865811004257"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2011.10.025","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2011.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}